skip to content
Detailed Quote
5i Report

Review of Knight Therapeutics

APR 01, 2017 - Pharmaceutical company focused on later stage commercialization of drugs. Lots of cash on the balance sheet, strongly performing loans and being one of the only performers in Canadian healthcare justify a rating upgrade to 'A-'.

Download Report
Company Profile
Interactive Chart
Key Ratios
Top Banner 5i Free Trial
Analyst Recommendations
5i Recent Questions

Q: Good morning Team! I would like to thank you all for the amazing technical work that you do for me! I work full time and it would be impossible to spend the time required to research companies.(even though I would love to) Above is a portfolio that I started and I am wondering what you would suggest to add? Investment timeline 10+ yrs.

Read Answer Asked by Brad on August 10, 2018
CMS Buy Now
Share Information
News and Media